Topic Listing for Insulet

Ability Grow Revenues Depends Part Retaining High Percentage Accounts Receivable Allowance Doubtful
Administration Adverse Changes General Economic Conditions United States Adversely
Allowance Doubtful Accounts Amendment Discontinuance Term
Annual Cash Incentive Bonuses Approval Amendment 2007 Stock Option Incentive Plan
Asset Valuation Audit Committee
Audit Committee Financial Expert Audit Fees
Base Salary Beneficial Ownership Reporting Compliance
Board Directors Board Directors Evaluation Program
Board Directors Stockholders Insulet Corporation Broad-based Benefits Programs
Cash Equivalents Cash Incentive Bonuses
Cautionary Regarding Forward-looking Statements Certain Risks Uncertainties
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act Changes Internal Control Over Financial Reporting
Choose Acquire Invest New Businesses Products Technologies Instead Claims Current Future Products Infringe Misappropriate Proprietary Rights
Code Ethics Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Competition Composition
Concentration Credit Risk Conclusion
Contract Manufacturers Component Suppliers Fail Comply Fdas Quality Contractual Obligations
Convertible Notes Convertible Notes Repayment Termination Term Loan
Cost Revenues Credit Security Agreement Contains Restrictions Covenants Limit Operating
Critical Accounting Policies Estimates Current Future Products Subject Recalls Even After Receiving
Current Insulin Therapy Dependent Third-party Suppliers Making Vulnerable Supply Problems Price
Diabetes Management Challenges Director Compensation
Director Compensation Table Director Qualifications
Disclosure Controls Procedures Dividend Policy
Documents Incorporated Reference Election Directors
Eligibility Employee Stock Purchase Plan
Employee Stock-based Awards Granted Subsequent 2006 Employee Stock-based Awards Prior 2006
Employees Employment Agreements
Equity Compensation Plan Information Estimates Preparation Financial Statements
Evaluation Program Board Directors Committees Exact Name Registrant Specified Charter
Executive Compensation Process Executive Compensation Programs
Executive Sessions Independent Directors Existing License Agreement Abbott Diabetes Care Inc Terminated
Expand Attempt Foreign Markets Affected New Business Risks Expenses Solicitation
Experience Significant Fluctuations Quarterly Results Operations Facility Agreement
Failure Secure Retain Adequate Coverage Reimbursement Omnipod System Fair Value Financial Instruments
Fees Billed Ernst Young Llp Financial Condition Results Operations Adversely Affected International Business
Financial Operations Overview Form 10-k
Form 10-q Found Violated Laws Protecting Confidentiality Patient Health Information
Future Capital Needs Uncertain Need Raise Additional Funds Future Clinical Studies Other Articles Published Diabetes Associations
Future Sales Shares Common Stock Public Market Perception General Administrative
General Administrative Expenses General Statement Purpose
Grants Plan-based Awards Held 2008
Held 2009 Http Wwwinsuletcom
Http Wwwinsuletcom Proxy Impairment Assets
Impairment Property Equipment Important Notice Regarding Availability Proxy Materials Stockholder Meeting
Income Taxes Incur Increased Costs Result Compliance Laws Regulations Affecting
Incurred Significant Operating Losses Since Inception Cannot Assure Incurred Significant Operating Losses Since Inception Currently Selling
Indemnifications Independence Members Board Directors
Independent Registered Public Accounting Firm Independent Registered Public Accounting Firmeb1
Index Index Consolidated Financial Statements
Insulet Corporation Insulet Corporation 2007 Stock Option Incentive Plan
Insulet Corporation Quarterly Report Form 10-q 2007 Table Intellectual Property
Intend Sponsor Market Studies Seeking Demonstrate Certain Aspects Interim Financial Statements
Internal Control Over Financial Information Inventories
Issuer Repurchases Equity Securities Liquidity
Loan Security Agreements Long-term Equity Incentive Compensation
Managements Annual Report Internal Control Over Financial Reporting Managing Diabetes
Manufacturing Quality Assurance Market Information
Market Opportunity Matters Concerning Independent Auditors
Need Expand Distribution Network Maintain Grow Business Revenues Need Initiate Lawsuits Protect Enforce Patents Other Intellectual
Need Raise Additional Funds Future Not Available Acceptable New 2007 Plan Benefits
Nominating Corporate Governance Committee Not Able Generate Sufficient Cash Service Indebtedness Including
Not Effectively Manage Growth Business Resources Become Strained Number Shares Available Issuance
Objectives Executive Compensation Programs Off-balance Sheet Arrangements
Omnipod System Operating Leases
Option Exercises Stock Vested Option Exercises Stock Vested 2007
Option Exercises Stock Vested 2008 Other Fees
Other Income Expense Other Matters
Other Rights Measures Taken Protect Intellectual Property Not Outstanding Equity Awards
Outstanding Equity Awards Year-end 2007 Outstanding Equity Awards Year-end 2008
Overview Part
Part Financial Information Performance Graph
Policies Governing Director Nominations Policies Procedures Respect Related Party Transactions
Policy Governing Director Attendance Annual Meetings Stockholders Policy Governing Securityholder Communications Board Directors
Potential Payments Termination Change-in-control Power Attorney Signatures
Price Common Stock Volatile Principles Consolidation
Procedures Recommendation Director Nominees Stockholders Proceeds
Process Identifying Evaluating Director Nominees Product Liability Suits Whether Not Meritorious Brought Against
Product Warranty Costs Property Equipment
Proxy Statement Recent Accounting Pronouncements
Recommendation Board Directors Redeemable Convertible Preferred Stock Conversion
Registration Rights Agreement Report Audit Committee Board Directors
Report Independent Registered Public Accounting Firm Research Development
Research Development Expenses Restricted Stock Awards Non-employees
Restructuring Expense Impairment Assets Restructuring Expenses
Restructuring Expenses Impairment Assets Restructuring Impairment Assets
Revenue Recognition Revenues
Sales Marketing Sales Marketing Expenses
Securities Authorized Issuance Equity Compensation Plans Security Agreement
Segment Reporting Severance Change Control Programs
Shareholder Rights Plan Shipping Handling Costs
Signatures Stock Based Compensation
Stock Option Grants Stock Option Incentive Plan
Stock Option Plans Stock-based Compensation Non-employees
Stockholder Proposals Subject Extensive Regulation Food Drug Administration Restrict Sales
Substantially Operations Conducted Single Location Inventory Held Disruption Substantially Operations Currently Conducted Single Location Disruption Facility
Success Depend Ability Attract Retain Personnel Summary Executive Compensation
Table Contents Tax Aspects Internal Revenue Code
Tax Fees Tax Withholding
Technological Breakthroughs Diabetes Monitoring Treatment Prevention Render Omnipod Third-party Reimbursement
Training Customer Support Types Awards
Unable Successfully Maintain Effective Internal Control Over Financial Vote Required
Vote Required Approval Warrants
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki